News Releases Year None202220212020201920182017 NuCana Reports Third Quarter 2022 Financial Results and Provides Business Update Nov 16, 2022 NuCana to Present at the Jefferies London Healthcare Conference Nov 08, 2022 NuCana Presents Positive Data on NUC-3373 at the 34th EORTC-NCI-AACR Annual Meeting 2022 Oct 26, 2022 NuCana Presents Promising Data on NUC-7738 at the European Society of Medical Oncology (ESMO) Annual Meeting 2022 Sep 12, 2022 NuCana Presents Favorable Data on NUC-3373 at the European Society of Medical Oncology (ESMO) Annual Meeting 2022 Sep 12, 2022 NuCana Announces Presentations at the European Society for Medical Oncology (ESMO) Congress 2022 Sep 06, 2022 NuCana to Participate in Citi's 17th Annual BioPharma Conference Aug 31, 2022 NuCana Reports Second Quarter 2022 Financial Results and Provides Business Update Aug 17, 2022 NuCana Regains Compliance with Nasdaq Minimum Bid Price Requirement Jul 27, 2022 German Court Rules that Gilead’s Sofosbuvir Infringes NuCana’s ‘190 Patent Jul 11, 2022 Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page next › Last page last »
NuCana Presents Positive Data on NUC-3373 at the 34th EORTC-NCI-AACR Annual Meeting 2022 Oct 26, 2022
NuCana Presents Promising Data on NUC-7738 at the European Society of Medical Oncology (ESMO) Annual Meeting 2022 Sep 12, 2022
NuCana Presents Favorable Data on NUC-3373 at the European Society of Medical Oncology (ESMO) Annual Meeting 2022 Sep 12, 2022
NuCana Announces Presentations at the European Society for Medical Oncology (ESMO) Congress 2022 Sep 06, 2022